HUL posts its strongest growth in 13 quarters in JQ26
Ask Iris
Frequently Asked Questions
Turnover was INR 17,184 crore with 10% underlying sales growth and 5% underlying volume growth. EBITDA was INR 3,947 crore and EBITDA margin was 23.0%.
Reported PAT was INR 2,680 crore, down 2% year on year, due to a one-off tax credit in the base quarter (June quarter 2025). PAT before exceptional items rose 9% to INR 2,731 crore.
Home Care led with 14% USG and INR 6,554 crore revenue. Beauty and Wellbeing delivered 12% USG with INR 4,083 crore revenue. Foods delivered 7% USG with INR 3,480 crore revenue. Personal Care delivered 4% USG with INR 2,624 crore revenue and low single-digit volume decline.
Management said commodity volatility persists and inflationary pressures are expected to continue in the short term. Consolidated EBITDA margin is expected to remain around the current guided range, supported by structural savings and calibrated pricing.
Management stated A&P spend stepped up sequentially to INR 1,657 crore, the highest in 11 quarters, and emphasized improved marketing ROI and competitive GRP levels.
Key initiatives cited were the Unilever Fragrance House in India, the Liquids Lab of the Future in Mumbai with up to 6x faster formulation development, WEF Lighthouse recognitions (8 designations across 6 sites), and an AI-enabled digital-first distribution centre launched in Vijayawada.
Management stated FY27 is expected to be better than FY26, led by portfolio and channel transformation, while monitoring monsoon and geopolitical developments and expecting stable FMCG demand.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
